期刊文献+

中期因子低表达对前列腺癌细胞增殖、侵袭及基质金属蛋白酶-9表达的影响 被引量:6

Effects of midkine gene low-expression on proliferation and invasion of prostate cancer and matrix metalloproteinase-9 gene expression
原文传递
导出
摘要 目的观察降低中期因子(MK)表达对人前列腺癌PC-5细胞增殖、侵袭及基质金属蛋白酶-9基因(MMP-9)表达的影响。方法用浓度为10nmol/L的MK基因小干扰RNA(siRNA)转染人前列腺癌PC-3细胞株,应用逆转录-聚合酶链反应(RT—PCR)方法检测MK和MMP-9mRNA水平,Transwell法和噻唑蓝(MTT)法检测PC-5细胞侵袭和增殖能力,平板克隆形成实验检测PC-3细胞克隆形成能力。结果与对照组比较,MK—siRNA组MK、MMP-9mRNA水平明显降低(P〈0.05)。Transwell实验结果显示,MK—siRNA组穿过滤膜的细胞数为(329.17±10.65)个,明显少于空白对照组[(580.00±10.20)个,P〈0.01]及空载对照组[(575.67±11.54)个,P〈0.01]。MTT法检测显示,MK—siRNA组细胞增殖受到抑制。平板克隆实验显示:MK—siRNA组克隆形成率为(35.33±2.80)%,低于空白对照组[(71.42±1.11)%,P〈0.01]。结论降低MK基因表达能抑制人前列腺癌PC-3细胞的侵袭及增殖,下调MMP-9基因表达,可能是其分子机制之一。 Objective To observe the effects of down-regulation of midkine (MK) gene expression on proliferation and invasion of prostate cancer PC-3 cells and matrix metalloproteinase (MMP) -9 gene expression. Methods After human prostate cancer PC-3 cells were transfected with midkine small interfering RNA (siRNA) at the concentration of 10 nmol/L, the mRNA expression levels of midkine and MMP-9 were examined by reverse transcription-polymerase chain reaction (RT-PCR). The invasion and proliferation ability was determined by Transwell and methyl thiazol tetrazolium ( MTT ) assay respectively. The PC-3 cell clony formation ability was evaluated by plate colony formation assay. Results As compared with the control group, the mRNA expression levels of midkine and MMP-9 gene were greatly inhibited in prostate cancer PC-3 cells transfected with MK-siRNA ( P 〈 0. 05 ). Transwell assay showed that the nmnber of PC-3 cells penetrating the membrane in the siRNA group (329. 17 -10. 65 ) was greatly decreased as compared with the Con-A group (580. 00 ± 10. 20,P 〈 0. 01 ) and Con-B group (575.67 ± 11.54, P 〈 0.01 ). MTT assay showed that the cell proliferation was significantly inhibited in MK-siRNA group. The result of plate colony formation assays showed that the colony formation rate in the siRNA group [ (35.33 ± 2.80) % ] was significantly decreased as compared with Con-A group [ (71.42 ± 1. 11 ) % ] ( P 〈 0. 01 ). Conclusion Down-regulation of midkine gene can inhibit the invasion and proliferation of prostate cancer cells through down-regulation of MMP-9 gene.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第5期1072-1074,共3页 Chinese Journal of Experimental Surgery
基金 江苏省自然科学基金资助项目(BK2011483)
关键词 中期因子 前列腺癌 增殖 侵袭 基质金属蛋白酶-9 Midkine Prostate cancer Proliferation Invasion Matrix metalloproteinase-9
  • 相关文献

参考文献8

  • 1Kadomatsu K,Tomomura M, Muramatsu T, et al. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation states of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis [ J ]. Biochem Biophys Res Commun, 1988,151 (3) :1312-1318.
  • 2Kadomatsu K, Muramatsu T. Midkine and pleiotrophin in neural devel- opment and cancer [ J ]. Cancer Lett,2004,204 ( 2 ) : 127-143.
  • 3崔飞伦,满昌峰,周永静,范钰.RNA干扰下调人滋养层细胞表面抗原-2基因表达对前列腺细胞侵袭及尿激酶纤溶酶原激活物蛋白的影响[J].中华实验外科杂志,2013,30(12):2500-2502. 被引量:4
  • 4Ikematsu S,Nakagawara A, Nakamura Y, et al. Correlation of elevated level of blood midkine with poor prognostic factors of human neuro- blastomas[ J]. Br J Cancer,2003,88 (10) : 1522-1526.
  • 5李良满,刘红波,张勇.中期因子和微血管密度在骨肉瘤中的表达及其意义[J].中华实验外科杂志,2006,23(1):114-114. 被引量:2
  • 6Jham BC,Costa NL, Silva JM, et al. Midkine expression in oral squa- mous cell carcinoma and leukoplakia[ J]. J Oral Pathol Med ,2012,41 ( 1 ) :21-26.
  • 7Hara T, Miyazaki H, Lee A, et al. Androgen receptor and invasion in prostate cancer [ J ]. Cancer Res,2008,68 (4) : 1128-1135.
  • 8Libra M, Scalisi A, Vella N, et al. Uterine cervical carcinoma: role of matrix metalloproteinases [ J ]. Int J Oncol, 2009,34 ( 4 ) : 897-903.

二级参考文献7

共引文献4

同被引文献57

  • 1杜岳峰,邢毅飞,曾甫清,陆鹏,刘先艮,肖亚军.人前列腺特异性抗原启动子调控的CXCR4-siRNA逆转录病毒载体的构建及其对前列腺癌细胞的生物学效应[J].中华肿瘤杂志,2007,29(7):489-494. 被引量:3
  • 2那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南(2014版)[M].北京:人民卫生出版社,2014:528.
  • 3Corey E, Brown LG, Quinn JE, et al. Zoledronic acid exhibits inhibito- ry effects on osteoblastic and osteolytic metastases of prostate cancer [J]. Clin Cancer Res,2003,9( 1 ) :295-306.
  • 4Bonfil RD, Sabbota A, Nabha S, et al. Inhibition of human prostate cancer growth ,osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor [ J ]. Int J Cancer,2006,118 ( 11 ) :2721-2726.
  • 5Chou TC. Drug combination studies and their synergy quantification u- sing the Chou-Talalay method [J]. Cancer IRes, 2010,70 ( 2 ) : 440- 446.
  • 6Beatrice D, Davide F, Calogero S, et al. Docetaxel in castration-resist- ant prostate cancer: a single-centre experience [ J ]. Cancer Invest, 2014,32(9) :445-450.
  • 7Tamaki H, Harashima N, Hiraki M, et al. Bcl-2 family inhibition sen- sitizes human prostate cancer cells to docetaxel and promotes unex- pected apoptosis under caspase-9 inhibition [ J ]. Oncotarget, 2014,5 (22) :11399-11412.
  • 8Wilson C, Scullin P, Worthington J, et al. Dexamethasone potentiates the antiangiogenie activity of docetaxel in castration-resistant prostate cancer[ J]. Br J Cancer,2008,99 (12) :2054-2064.
  • 9Chou TC, Talalay P. Quantitative analysis of dose-effect relationships : the combined effects of multiple drugs or enzyme inhibitors [J]. Adv Enzyme Reaul. 1984.22:27-55.
  • 10张晓光,徐勇,张志宏,杨阔,乔宝民,权昌益.短发夹RNA对前列腺癌细胞中PIM-1基因沉默效应的研究[J].天津医药,2009,37(7):529-531. 被引量:3

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部